Search results
Gentamicin is an antibiotic used to treat several types of bacterial infections. This may include bone infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, and sepsis among others. It is not effective for gonorrhea or chlamydia infections.
La gentamicina es un antibiótico del grupo de los aminoglucósido, producido por la Micromonospora purpurea, [1] utilizado como antibiótico de amplio espectro y acción bactericida para el tratamiento de infecciones causadas por bacilos gramnegativos, como Pseudomonas aeruginosa, Klebsiella pneumoniae o Proteus mirabilis.
Gentamicin is an antibiotic used to treat several types of bacterial infections. This may include bone infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, and sepsis among others. It is not effective for gonorrhea or chlamydia infections.
Gentamicin. General. Type: Aminoglycosides. Dosage Forms: IM; IV. Common Trade Names: Genticyn, Garamycin, Gentak. Adult Dosing. All: If obese, use Adjusted Weight = IBW + 0.4 x (ABW - IBW) All: Adjust repeat dosing based on levels. General. Extended Interval. 5-7mg/kg IV q24h. First Dose: 5-7mg/kg IV. Conventional. 1-1.7mg/kg IM/IV q8h.
Jan 1, 2023 · Gentamicin is an aminoglycoside antibiotic that was first discovered in the late 1950s by scientists at the pharmaceutical company Schering Corporation (now part of Merck & Co.). It was first approved for use in the United States in 1963 and has since become a widely used antibiotic for the treatment of a variety of bacterial
Apr 10, 2023 · Gentamicin is an aminoglycoside antibiotic used in the treatment of several gram-negative infections. It should be indicated based on patient age, symptoms, signs at presentation, and local antimicrobial resistance patterns to enhance the probability of successful treatment in bacterial septicemia, meningitis, urinary tract infections ...
Gentamicin is considered to be more vestibulotoxic than cochleotoxic compared to other aminoglycosides. Unfortunately, gentamicin-related ototoxicity does not correlate with cumulative dosing, peak and trough levels, or dosing schedule. The unpredictability of ototoxicity supports close monitoring of the patient throughout treatment.